Frontage extends pain medication development services
The approval enables pharma firms that develop pain therapeutics to rely on Frontage for controlled-substance product development support services. Frontage has upgraded its units, security and personnel procedures
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.